The latest drug-discovery AI announcement from the University of Virginia School of Medicine deserves attention, but not for the usual reason. The easy storyline is speed. The more important storyline is realism.

The new living-donor prize challenge from the Department of Health and Human Services is a useful signal, but the signal matters more than the purse. The federal government is implicitly acknowledging that living kidney donation has not been held back by a lack of goodwill or a lack of clinical capability.

The April 14 sentencing of a Florida nursing assistant in an $11.4 million orthotic-brace fraud scheme is easy to treat as a familiar enforcement item. According to the Department of Justice, the defendant used a Florida durable medical equipment supplier to bill Medicare for braces that beneficiaries did not request or need, while concealing true ownership and relying on illegal kickbacks to obtain signed doctors’ orders, as outlined in the April 14 sentencing announcement.

The Centers for Medicare & Medicaid Services is using its 2026 proposed rule on interoperability and drug prior authorization to do more than shorten approval timelines.